Cures Within Reach

The innovative medical research philanthropy Cures Within Reach has announced a marketing partnership with PatientsLikeMe to work together to improve patient lives.

Cures Within Reach is supporting research at Rush University Medical Center to accumulate data supporting a repurposed device for the treatment of Multiple Sclerosis as it seeks FDA-approval.

Batten Disease is a fatal, rare genetic disease affecting the nervous system and most often affecting children. Two families in the Chicago area touched by Batten are making a big difference in research through funds raised by their organizations.

On Monday, June 24th, 24 Golfers played over 1000 holes of golf at Ravinia Green Country Club to fund research into an immediately usable treatment for autism through Chicago’s philanthropic organization, Cures Within Reach.

On Monday, June 24th, Golfers will swing their way through 1400 holes of golf at Ravinia Green Country Club to fund research into an immediately usable treatment for autism through Chicago's philanthropic organization, Cures Within Reach.

According to a recent study commissioned by The Illinois Biotechnology Industry Organization (iBIO) and conducted by Ernst & Young LLP, the Midwest and Illinois are part of the most vibrant bioscience hub in the United States.

Some of the most prominent leaders in bioscience and related industries will gather at the Standard Club in Chicago on Thursday, June 13, to celebrate the growth of the bioscience industry in the Midwest.

Understanding Drug Development will be the second webcast in the RARE Webinar Series providing relevant information to patients and caregivers battling rare diseases, which are defined as diseases that affect fewer than 200,000 people in the US and...

Jasper Against Batten at Cures Within Reach, a 501(c)3 not-for-profit located in IL, is collaborating with an int'l coalition to fund “Global Gene Transfer for Batten Disease” research at the UNC Gene Therapy Center, announced Dr. Bruce Bloom.

Each year the designation of the final day of February as Rare Disease Day generates increased awareness of the 7,000-plus rare disorders and fuels a greater urgency to develop more treatments for rare disease patients.